Impact of hepatitis A vaccination on health care utilization in the United States, 1996-2004

Vaccine

Volumn 25, Issue 18, 2007, Pages 3581-3587

  Zhou, Fangjun ^a   Shefer, Abigail ^a   Weinbaum, Cindy ^b   McCauley, Mary ^a   Kong, Yuan ^c  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c SCIENCE APPLICATIONS INTERNATIONAL CORPORATION   (United States)

Author keywords

Health care utilization; Hepatitis A; Medical expenditure; Vaccination

Indexed keywords

HEPATITIS VACCINE;

ADOLESCENT; ADULT; AGED; AMBULATORY CARE; ARTICLE; CHILD; CONSULTATION; CONTROLLED STUDY; DATA BASE; EMPLOYER; ENERGY EXPENDITURE; FEMALE; GROUPS BY AGE; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HEPATITIS A; HOSPITALIZATION; HUMAN; MALE; MEDICAL CARE; POISSON DISTRIBUTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; UNITED STATES; VACCINATION;

ADOLESCENT; ADULT; AGED; AMBULATORY CARE; CHILD; CHILD, PRESCHOOL; FEMALE; HEALTH EXPENDITURES; HEALTH SERVICES; HEPATITIS A; HEPATITIS A VACCINES; HEPATITIS A VIRUS; HOSPITALIZATION; HUMANS; IMMUNIZATION PROGRAMS; INFANT; INFANT, NEWBORN; INSURANCE, HEALTH; MALE; MIDDLE AGED; OFFICE VISITS; PROGRAM EVALUATION; UNITED STATES; VACCINATION;

EID: 34247133369     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.01.081     Document Type: Article

References (21)

1. Centers for Disease Control Prevention. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 45 (1996) 1-30
2. Centers for Disease Control Prevention. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 48 RR-12 (1999) 1-37
3. Centers for Disease Control Prevention. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 55 RR07 (2006) 1-23
4. Armstrong G.L., and Bell B.P. Hepatitis A virus infections in the United States: model-based estimates and implications for childhood immunization. Pediatrics 109 (2002) 839-845
5. ® Database, Ann Arbor, MI: The MEDSTAT Group Inc., 2000.
6. Consumer Price Indexes. US Department of Labor, Bureau Of Labor Statistics; 2006. Available at: http://www.bls.gov/cpi/home.htm#data. [Accessed 23.8.2006].
7. Projections of the total resident population by 5-year age groups, and sex with special age categories: Middle series, 2001 to 2005. US Bureau of Census; 2004. Available at: http://www.census.gov/population/projections/nation/summary/np-t3-b.txt [Accessed 26.10.2004].
8. Resident population estimates of the united states by age and sex: April 1, 1990 to July 1, 1999, with short-term projection to November 1, 2000. US Bureau of Census; 2004. Available at: http://www.census.gov/population/estimates/nation/intfile3-1.txt [Accessed 26.10.2004].
9. Wasley A., Samandari T., and Bell B.P. Incidence of hepatitis A in the United States in the era of vaccination. JAMA 294 (2005) 194-201
10. Samandari T., Bell B.P., and Armstrong G.L. Quantifying the impact of hepatitis A immunization in the United States, 1995-2001. Vaccine 22 (2004) 4342-4350
11. Dagan R., Leventhal A., Anis E., Slater P., Ashur Y., and Shouval D. Incidence of hepatitis A in Israel following universal immunization of toddlers. JAMA 294 (2005) 202-210
12. Hanna J.N., Hills S.L., and Humphreys J.L. Impact of hepatitis A vaccination of Indigenous children on notifications of hepatitis A in north Queensland. Med J Aust 181 (2004) 482-485
13. Jajosky R.A., Hall P.A., Adams D.A., Dawkins F.J., Sharp P., Anderson W.J., et al. Summary of notifiable diseases-United States, 2004. MMWR Morb Mortal Wkly Rep 53 (2006) 1-79
14. Whitney C.G., Farley M.M., Hadler J., Harrison L.H., Bennett N.M., Lynfield R., et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med 348 (2003) 1737-1746
15. Taheri P.A., Butz D.A., and Greenfield L.J. Academic health systems management: the rationale behind capitated contracts. Ann Surg 231 (2000) 849-859
16. Amon J.J., Darling N., Fiore A.E., Bell B.P., and Barker L.E. Factors associated with hepatitis a vaccination among children 24 to 35 months of age: United States, 2003. Pediatrics 117 (2006) 30-33
17. Centers for Disease Control Prevention. Hepatitis a vaccination coverage among children aged 24-35 months-United States, 2003. MMWR Morb Mortal Wkly Rep 54 (2005) 141-144
18. McQuillan G.M., Kruszon-Moran D., Kottiri B.J., Curtin L.R., Lucas J.W., and Kington R.S. Racial and ethnic differences in the seroprevalence of 6 infectious diseases in the United States: data from NHANES III, 1988-1994. Am J Public Health 94 (2004) 1952-1958
19. Davis M.M., Patel M.S., and Gebremariam A. Decline in varicella-related hospitalizations and expenditures for children and adults after introduction of varicella vaccine in the United States. Pediatrics 114 (2004) 786-792
20. National Center for Health Statistics. Health, United States, 2004. With chartbook on trends in the health of Americans. Hyattsville, Maryland: National Center for Health Statistics; 2004.
21. Perrin E.B., and Koshel J.J. Assessment of performance measure for public health, substance abuse, and mental health (1997), National Academy Press, Washington, DC